Roche Holding AG - ADR
RHHBY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$392.71B
Close$
Earnings Call Q2 2024
July 25, 2024 - AI Summary
Group sales increased by 8% in the first half of the year, excluding COVID impact.
Pharma division saw strong growth in base business with an 8% increase in sales.
Diagnostics division also experienced solid growth with a 9% increase in sales.
Exclusive for Stockcircle Pro members
Sign up
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $392.71 Billion |
|---|---|
| Enterprise Value | $418.92 Billion |
| Annual dividend | $1.55 |
| Dividend yield | 2.51% |
| Earnings per Share | $2.02 |
| Beta | 0.35 |
| Outstanding Shares | 6,473,904,000 |
Return
| Return on Equity | 66.85% |
|---|---|
| Return on Assets | 22.26% |
| Return on Invested Capital | 42.92% |
Valuation & Multiples
| P/E Ratio | 25.41 |
|---|---|
| PEG | -325.98 |
| Price to Sales | 3.19 |
| Price to Book Ratio | 12.13 |
| Enterprise Value to Revenue | 3.4 |
| Enterprise Value to EBIT | 14.15 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.97 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 23, 2026
EPS
$1.66
Est. $1.58Revenue
$38.52 B
Est. $38.14 BNext Earnings Call
Expected Date
January 28, 2027
EPS Estimate
$1.47
Consensus analyst estimateRevenue Estimate
$37.23 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 0.05% |
|---|---|
| Total Invested | $110.17M▼ 60.82% |
| Investors Holding | 37▼ 34.00% |
About Roche Holding AG
103,249 employees
CEO: Severin Schwan
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ...